| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | ROSE ERIC A MD | Director | Payment of Exercise | Common Stock | 157 | $16.04 | $2.5k | | 05/17/2023 |
| 05/17/2023 | ROSE ERIC A MD | Director | Exercise | Warrant (Right to Buy) | 2.3k | $1.08 | $2.5k | | 05/17/2023 |
| 05/10/2023 | Fain Eric S | Director | Exercise | Warrant (Right to Buy) | 2.9k | $1.08 | $3.1k | By the Fain Living Trust | 05/10/2023 |
| 04/12/2023 | Smith Geoffrey Wade | Director | Exercise | Right to Receive Earnout Shares | 55.8k | $0.00 | $0 | By Ascent Biomedical Ventures Synecor, LP | 04/12/2023 |
| 04/12/2023 | Smith Geoffrey Wade | Director | Exercise | Right to Receive Earnout Shares | 228.1k | $0.00 | $0 | By Ascent Biomedical Ventures II, LP | 04/12/2023 |
| 04/12/2023 | Smith Geoffrey Wade | Director | Exercise | Right to Receive Earnout Shares | 43.8k | $0.00 | $0 | By Ascent Biomedical Ventures II NY, LP | 04/12/2023 |
| 04/12/2023 | Smith Geoffrey Wade | Director | Exercise | Right to Receive Earnout Shares | 758 | $0.00 | $0 | | 04/12/2023 |
| 04/12/2023 | Fain Eric S | Director | Exercise | Right to Receive Earnout Shares | 4.8k | $0.00 | $0 | By the Fain Living Trust | 04/12/2023 |
| 04/12/2023 | Aryeh Jason | Director | Exercise | Right to Receive Earnout Shares | 11.2k | $0.00 | $0 | | 04/12/2023 |
| 04/12/2023 | Connealy Pamela Ann | Director | Exercise | Right to Receive Earnout Shares | 758 | $0.00 | $0 | | 04/12/2023 |
| 04/12/2023 | Kaswan Michael | CFO | Exercise | Right to Receive Earnout Shares | 29k | $0.00 | $0 | | 04/12/2023 |
| 04/12/2023 | Mika Yuval | See Remarks | Exercise | Right to Receive Earnout Shares | 8.9k | $0.00 | $0 | | 04/12/2023 |
| 04/12/2023 | Hochman David P | See Remarks | Exercise | Right to Receive Earnout Shares | 29.6k | $0.00 | $0 | | 04/12/2023 |
| 04/12/2023 | Hochman David P | See Remarks | Exercise | Right to Receive Earnout Shares | 11.2k | $0.00 | $0 | By the DPH 2008 Trust | 04/12/2023 |
| 04/12/2023 | Hochman David P | See Remarks | Exercise | Right to Receive Earnout Shares | 683 | $0.00 | $0 | By the NSH 2008 Family Trust | 04/12/2023 |
| 04/12/2023 | Sherman Darren | See Remarks | Exercise | Right to Receive Earnout Shares | 15k | $0.00 | $0 | | 04/12/2023 |
| 01/26/2023 | Mika Yuval | See Remarks | Grant | | 234.2k | $10.00 | $2.3M | | 01/26/2023 |
| 01/26/2023 | Kaswan Michael | CFO | Grant | | 192.6k | $10.00 | $1.9M | | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Common Stock | 3.5k | $0.00 | $0 | | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Common Stock | 201.3k | $0.00 | $0 | By Ascent Biomedical Ventures II NY, LP | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Common Stock | 1M | $0.00 | $0 | By Ascent Biomedical Ventures II, LP | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Common Stock | 256.6k | $0.00 | $0 | By Ascent Biomedical Ventures Synecor, LP | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Warrants (Right to Buy) | 43.9k | $21.51 | $944.9k | By Ascent Biomedical Ventures II NY, LP | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Warrants (Right to Buy) | 136.1k | $21.51 | $2.9M | By Ascent Biomedical Ventures II, LP | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Warrants (Right to Buy) | 519 | $21.51 | $11.2k | By Ascent Biomedical Ventures Synecor, LP | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Stock Options (Right to Buy) | 18.6k | $4.30 | $80k | | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Stock Options (Right to Buy) | 7k | $4.30 | $30k | | 01/26/2023 |
| 01/26/2023 | Smith Geoffrey Wade | Director | Grant | Stock Options (Right to Buy) | 23.2k | $10.00 | $232.5k | | 01/26/2023 |
| 01/26/2023 | RTW INVESTMENTS, LP | 10% Owner | Grant | Common Stock | 2.3M | $0.00 | $0 | See footnote | 01/26/2023 |
| 01/26/2023 | Hochman David P | See Remarks | Grant | Common Stock | 51.3k | $0.00 | $0 | By the DPH 2008 Trust | 01/26/2023 |
| 01/26/2023 | Hochman David P | See Remarks | Grant | Common Stock | 3.1k | $0.00 | $0 | By the NSH 2008 Family Trust | 01/26/2023 |
| 01/26/2023 | Hochman David P | See Remarks | Grant | Nonstatutory Stock Option (Right to Buy) | 194.1k | $4.30 | $834.5k | | 01/26/2023 |
| 01/26/2023 | Hochman David P | See Remarks | Grant | Nonstatutory Stock Option (Right to Buy) | 31k | $4.06 | $125.9k | | 01/26/2023 |
| 01/26/2023 | Connealy Pamela Ann | Director | Grant | | 1.5k | $0.00 | $0 | | 01/26/2023 |
| 01/26/2023 | Hochman David P | See Remarks | Grant | Nonstatutory Stock Option (Right to Buy) | 300.2k | $10.00 | $3M | | 01/26/2023 |
|